We aspire to make medicines at the highest level, reliably and repeatedly. We focus on hard-but-solvable problems. We match compelling disease targets to the best drug toolkit for no-regrets medicines capable of delivering in the clinic.
Our in-house R&D model combines proven wet lab drug discovery techniques with computing power. Our team includes experts who engineer novel assays, build in silico prediction models, and synthesize compounds and biologics capable of bending the most difficult projects towards success.
Hard-to-treat diseases require hard-hitting medicines. That’s why we prioritize safety side-by-side with efficacy. A wide therapeutic window means more intense dosing and a greater chance for disease impact.